Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Multiple Sclerosis Clinical Trials

116 recruiting trials for Multiple Sclerosis. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
116
Total Trials
116
Recruiting Now
4
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGNCT05635266

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

To collect, preserve, and/or distribute annotated biospecimens and associated medical data to institutionally approved, investigator-directed biomedical research to discover and...

Sponsor: Sanguine BiosciencesEnrolling: 200001 location
RECRUITINGNCT05819008

Remote Neuropsychological Assessment of Patients With Neurological Disorders and Injuries

For the last decades, many aspects of human life have been altered by digital technology. For health care, this have opened a possibility for patients who have difficulties...

Sponsor: Umeå UniversityEnrolling: 3501 location
RECRUITINGNCT03217396

Biomarkers of Synaptic Damage in Multiple Sclerosis

A prospective and retrospective cohort study of about five years will be performed on blood and cerebrospinal fluid samples taken for diagnostic reasons from recruited patients...

Sponsor: Neuromed IRCCSEnrolling: 3001 location
RECRUITINGNCT07202494

Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience...

The MESO7 study is a prospective observational research project designed to investigate the mechanisms of resilience and neurodegeneration in neurological diseases and healthy...

Sponsor: Assistance Publique Hopitaux De MarseilleEnrolling: 7001 location
RECRUITINGNCT05934188

Exploring the Gut-Brain Axis in Ageing and Neurodegeneration

Neurodegenerative diseases are a major health concern due to their growing societal implications and economic costs. The identification of early markers of pathogenic mechanisms...

Sponsor: IRCCS San Camillo, Venezia, ItalyEnrolling: 2003 locations
RECRUITINGPhase 4NCT07225361

Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis

In this prospective, open-label, single-arm, single-institution trial, the investigators will accomplish the following two aims: 1. study the safety and tolerability of...

Sponsor: Northwestern UniversityEnrolling: 401 location
RECRUITINGPhase 1NCT05003388

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for MS

This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of multiple...

Sponsor: The Foundation for Orthopaedics and Regenerative MedicineEnrolling: 152 locations
RECRUITINGNCT06764602

Observational, Retrospective, Multicenter, Nonprofit Study on the Prevalence of Renal Involvement in Pediatric Patients...

Observational, retrospective, multicenter, nonprofit study on the prevalence of renal involvement in pediatric patients with tuberous sclerosis.

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di BolognaEnrolling: 801 location
RECRUITINGNCT03850301

Validation of the 18 kiloDalton Translocator Protein (TSPO) as a Novel Neuroimmunodulatory Target

In multiple sclerosis (MS) cells of the immune system attack the brain causing tissue damage. In secondary progressive MS (SPMS) these repeated immune attacks have stopped but...

Sponsor: Imperial College LondonEnrolling: 441 location
RECRUITINGNCT06195800

Biomarkers of aHSCT

The underlying disease mechanisms which occur in patients with immune mediation neurological diseases, such as Multiple Sclerosis (MS), are incompletely understood. For such...

Sponsor: Sheffield Teaching Hospitals NHS Foundation TrustEnrolling: 151 location
RECRUITINGPhase 1NCT07295847

A Study of AZD0120 in Autoimmune Diseases

This trial is a Phase 1b, open-label, multi-center, clinical study of AZD0120, a BCMA/CD19 dual targeting CAR+ T-cell therapy, to evaluate the safety and tolerability in adult...

Sponsor: AstraZenecaEnrolling: 2718 locations
RECRUITINGNCT06849882

Dubousset Functional Test: an Investigation of Its Validity and Reliability in Individuals with Multiple Sclerosis

Multiple sclerosis (MS) is an autoimmune disease characterized by neuroinflammation and neurodegeneration in the central nervous system. The disease affects the white matter,...

Sponsor: Inonu UniversityEnrolling: 331 location
RECRUITINGNCT06312046

Motor-cognitive Performance in People With Multiple Sclerosis

Having a neurological disease such as multiple sclerosis (MS) leads to difficulties in balance and gait with or without concurrent performance of cognitive tasks, hindering...

Sponsor: Karolinska InstitutetEnrolling: 901 location
RECRUITINGNCT05516537

Examining the Effects of a Remotely-delivered, Racially-tailored Exercise Training Program for Immediate and Sustained...

The proposed project involves a high-quality randomized controlled (RCT) design that examines the effects of a remotely-delivered, racially-tailored exercise training program for...

Sponsor: University of Illinois at ChicagoEnrolling: 1001 location
RECRUITINGNCT07342777

EXpain Trial - Exercise an a Non-pharmacological Pain-relieving Treatment in People With Multiple Sclerosis

The primary goal of this study is to test whether 12 weeks of progressive resistance exercise is an effective non-pharmacological treatment for reducing pain in people with...

Sponsor: University of AarhusEnrolling: 1161 location
RECRUITINGPhase 1NCT05849467

Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal...

Background: Multiple sclerosis (MS) and progressive multifocal leukoencephalopathy (PML) are disorders that affect the central nervous system (CNS). The CNS includes the brain,...

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)Enrolling: 151 location
RECRUITINGNCT00001532

Role of Genetic Factors in the Development of Lung Disease

This study is designed to evaluate the genetics involved in the development of lung disease by surveying genes involved in the process of breathing and examining the genes in lung...

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)Enrolling: 35002 locations
RECRUITINGNCT06112639

The DANCEREX Proof-of-Concept Study for Chronic Neurological Disorders

The goal of this clinical trial is to test a new digital therapeutic solution which combines a holistic, multidimensional rehabilitation program based on dance and music with an...

Sponsor: Fondazione Don Carlo Gnocchi OnlusEnrolling: 1923 locations
RECRUITINGNCT05735691

High-Intensity, Dynamic-stability Gait Training in People With Multiple Sclerosis

The goal of this clinical trial is to improve walking speed, balance, and walking in the community for people with multiple sclerosis. This trial involves intense exercise...

Sponsor: Marquette UniversityEnrolling: 1502 locations
RECRUITINGNCT07111637

Artificial Intelligence-Assisted Magnetic Resonance Imaging for Quality, Efficiency and Equity in the National Health...

Multiple Sclerosis (MS) is a long-term disease that affects over 150,000 people in the UK. Starting treatment early is important for managing Multiple Sclerosis (MS). It is also...

Sponsor: Queen Mary University of LondonEnrolling: 13361 location
RECRUITINGNCT07182903

Fatigue in MS: From Invisible to Measurable

Fatigue is one of the most common and burdensome symptoms of MS, but its precise cause remains unknown, and an effective treatment is lacking. Previous research has shown that the...

Sponsor: University Medical Center GroningenEnrolling: 401 location
RECRUITINGNCT04573673

Transcutaneous Tibial Neuro-stimulation to Improve Voiding Dysfunction in Multiple Sclerosis.

The present trial is designed to assess the efficacy and safety of transcutaneous tibial neuro-stimulation (TTNS) in improving bladder emptying in multiple sclerosis (MS)...

Sponsor: University Hospital, LilleEnrolling: 681 location
RECRUITINGPhase 1 / Phase 2NCT07477639

Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

The goal of this clinical trial is to treat male and female participants with two types of Multiple Sclerosis (MS) called primary progressive or secondary progressive MS. The...

Sponsor: Tr1X, Inc.Enrolling: 392 locations
RECRUITINGNCT07452562

Hesperidin RCT in MS

This study is a randomised, double-blind, placebo-controlled trial investigating the effects of Hesperidin supplementation on cognitive function, fatigue, and stress....

Sponsor: Swansea UniversityEnrolling: 601 location
RECRUITINGNCT06940323

Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)

PRISMA, is a pregnancy registry study, focused on comprehensively collecting information about pregnancy in women with chronic neurological conditions from across the United...

Sponsor: University of California, San FranciscoEnrolling: 2501 location
RECRUITINGNCT07058896

Unravelling The Optimisation And Consolidation Of Motor Skills In People With Multiple Sclerosis With Severe Gait...

Multiple sclerosis (MS) is a progressive neurological disorder that often leads to severe gait impairment, limiting mobility and reducing the patient's quality of life. Motor...

Sponsor: University Hospital of FerraraEnrolling: 181 location
RECRUITINGNCT00001975

Study of Skin Tumors in Tuberous Sclerosis

Tuberous sclerosis is a rare, hereditary disease in which patients develop multiple tumors. Although not cancerous, the tumors can affect various organs, including the heart,...

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)Enrolling: 4001 location
RECRUITINGNCT06591429

Smoldering Inflammation in MS

The goal of this observational study is to learn about inflammation in those with relapsing remitting Multiple Sclerosis (MS). The main questions it aims to answer are: * How...

Sponsor: Washington University School of MedicineEnrolling: 251 location
RECRUITINGPhase 1NCT06680037

A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

The main objective of the study is to determine the recommended phase 2 dose (RP2D) of Azercabtagene zapreleucel (azer-cel).

Sponsor: TG Therapeutics, Inc.Enrolling: 328 locations
RECRUITINGNCT07360977

Myrosinase Bioactivated Gglucoraphanin for the Treatment of Neurodegenerative Diseases (GRA-MYR-ND)

Glucosinolates (GLs) are phytocompounds mainly found in the Cruciferae (Brassicacea) and Moringa oleifera plants. The hydrolysis of GLs by myrosinase led to the production of...

Sponsor: IRCCS Centro Neurolesi Bonino PulejoEnrolling: 3001 location
RECRUITINGPhase 1 / Phase 2NCT06351592

First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation...

This study is researching an experimental drug called ALN-SOD (called "study drug"). This study is focused on people with Amyotrophic Lateral Sclerosis (ALS) caused by a change in...

Sponsor: Regeneron PharmaceuticalsEnrolling: 4216 locations
RECRUITINGNCT05953519

Meeting an Unmet Need in Multiple Sclerosis

The primary objectives of this study is to examine the efficacy of the Unified Protocol in decreasing depression and anxiety among individuals with MS and the secondary outcomes...

Sponsor: Kessler FoundationEnrolling: 241 location
RECRUITINGNCT02433028

Swiss Multiple Sclerosis Cohort-Study

The Swiss MS Cohort Study (SMSC) is a multicentre cohort study that involves 8 Swiss Multiple Sclerosis centres. The key aims of the SMSC are 1. To maintain a long-term cohort...

Sponsor: University Hospital, Basel, SwitzerlandEnrolling: 12008 locations
RECRUITINGNCT07175792

Accuracy of Motor Performance Perception in Multiple Sclerosis

The aim of this study is to characterize perceptive abilities in PwMS compared to controls when performing prolonged functional tasks such as walking and repeated standing from a...

Sponsor: Hasselt UniversityEnrolling: 883 locations
RECRUITINGNCT06455332

Predictive Value of the Optic Nerve Involvement in Clinically Isolated Syndrome

Optic neuritis (ON) represents around 30% of clinical presentation of clinically isolated syndrome (CIS). Asymptomatic optic nerve involvement is very frequent in all stage of...

Sponsor: University Hospital, LilleEnrolling: 2001 location
RECRUITINGNCT06450418

Digital App for Speech & Health Monitoring

Many people living with neurodegenerative conditions like dementia, motor neuron disease (MND), multiple sclerosis (MS), and Parkinson's disease (PD), suffer from speech problems....

Sponsor: University of EdinburghEnrolling: 1501 location
RECRUITINGNCT00001465

Study of the Disease Process of Lymphangioleiomyomatosis

Pulmonary lymphangioleiomyomatosis (LAM) is a destructive lung disease typically affecting women of childbearing age. Currently, there is no effective therapy for the disease and...

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)Enrolling: 20001 location
RECRUITINGPhase 3NCT06008249

Platform Trial to Assess the Efficacy of Multiple Drugs in Amyotrophic Lateral Sclerosis (ALS)

The objective of this phase III, placebo-controlled platform study is to investigate the efficacy of drugs for patients with ALS (Amyotrophic lateral sclerosis).

Sponsor: Stichting TRICALS FoundationEnrolling: 17113 locations
RECRUITINGPhase 3NCT06675955

An Extension Study to Assess Impact of Multiple Sclerosis (MS) on Physical Function and Provide Continued Ocrelizumab...

The study will evaluate the physical impact of MS from participant's perspective, provide continued access to ocrelizumab and assess the safety and tolerability of ocrelizumab....

Sponsor: Hoffmann-La RocheEnrolling: 50020 locations
RECRUITINGNCT06732674

Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases

The RMD-mILDer trial is a home monitoring strategy trial aiming to improve management of interstitial lung disease related to rheumatic diseases applying eHealth technology. It...

Sponsor: Oslo University HospitalEnrolling: 2181 location
RECRUITINGNCT06805318

Feasibility of a Vocational Rehabilitation Intervention for Job Retention in Workers With MS-RiaLSM Intervention Project

Multiple sclerosis (MS) is an autoimmune demyelinating disease of the central nervous system with both inflammatory and degenerative characteristics that affects approximately...

Sponsor: Fondazione Italiana Sclerosi MultiplaEnrolling: 302 locations
RECRUITINGPhase 2NCT07074886

A Study to Assess Bioequivalence of Two Subcutaneous (SC) Formulations of Ocrelizumab in Participants With Multiple...

The main purpose of this study is to assess the bioequivalence of ocrelizumab SC test formulation to the marketed ocrelizumab SC reference formulation in participants with either...

Sponsor: Hoffmann-La RocheEnrolling: 18220 locations
RECRUITINGNCT05204459

MS-ResearchBiomarkerS

This study is being conducted to investigate risk factors for disability progression in Multiple Sclerosis and related disorders (MSRD). The primary goal is to assess whether...

Sponsor: Cedars-Sinai Medical CenterEnrolling: 10001 location
RECRUITINGPhase 2NCT06782490

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis...

The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986368 in participants with Multiple Sclerosis Spasticity

Sponsor: CelgeneEnrolling: 20020 locations
RECRUITINGNCT07222618

"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS

The goal of this observational study is to validate a novel, cost-effective method for real-world assessment using patient-acquired "selfie" videos in people with multiple...

Sponsor: University of California, San FranciscoEnrolling: 3001 location
RECRUITINGNCT07202195

At Home Use of Stimulation Suits for Managing MS Symptoms

This study is being carried out at Multiple Sclerosis (MS) centers to evaluate whether a full-body stimulation suit at home can help people with Multiple Sclerosis (pwMS) reduce...

Sponsor: Daphne KosEnrolling: 702 locations
RECRUITINGNCT07438964

Non-invasive Brain Stimulation in Multiple Sclerosis Fatigue

The neurobiological basis of central fatigue in multiple sclerosis remained unclear so far. This study investigates reward-related brain mechanisms, inflammation, and their...

Sponsor: Charite University, Berlin, GermanyEnrolling: 841 location
RECRUITINGPhase 3NCT04047628

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

This is a multi-center prospective rater-masked (blinded) randomized controlled trial of 156 participants, comparing the treatment strategy of Autologous Hematopoietic Stem Cell...

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)Enrolling: 15620 locations
RECRUITINGNCT06964581

Cognitive Rehabilitation of Deficits in Patients With Multiple Sclerosis

Non-Inferiority Study, Post-Market Clinical Investigation with a Device, Single-Blind Randomized Controlled Trial in a Cohort of Patients Diagnosed with Multiple Sclerosis (MS)....

Sponsor: Universita di VeronaEnrolling: 601 location
RECRUITINGPhase 1 / Phase 2NCT04121468

A Phase I Double Blind Study of Metformin Acting on Endogenous Neural Progenitor Cells in Children and Young Adults...

A randomized multiple baseline feasibility trial where participants will start taking metformin at one of 3 randomly determined points (3-months, 6-months or 9 months) during the...

Sponsor: The Hospital for Sick ChildrenEnrolling: 201 location

Showing 50 of 116 trials.Search all Multiple Sclerosis trials